The US FDA is looking to purchase a generic EpiPen and competing epinephrine products for testing in its labs, potentially to try to determine how competition for it and other combination products could enter the market.
Authorized generics for Mylan NV's EpiPen (epinephrine intramuscular injection) and Impax Laboratories Inc.'s Adrenaclick (epinephrine subcutaneous injection), as...